Carl Magnus Wahlgren

MD, Professor
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
Stockholm, Stockholms Lan, Sweden

Presentation(s):

• PB0850 - Tocilizumab Reduces Hypercoagulation in COVID-19 - Perspectives from The Coagulation and Immunomodulation Covid Assessment Clinical Trial.

  Monday, June 24, 2024
  13:45 – 14:45 ICT